Expected 12-month results include 15 to 20% body weight loss (65 to 100+ pounds for a 400-pound person), 6 to 10 inch waist circumference reduction, transformative improvement in daily functional capacity, and resolution or significant improvement of multiple obesity-related conditions
1 memo to plan members, IBX officials stated that coverage for these high-cost drugs could drive up premiums for everyone, not just people taking the medications
Both medications have their roles in obesity management, and the choice between the two will often fall on individual patient needs, preferences, medical history, and a healthcare providers recommendation
Contamination: Without strict oversight from inspected facilities, there is a risk of bacteria or harmful additives
Starting at the lowest effective dosesuch as PlexusDx's Microdose GLP-1 Protocol at $129/moallows gradual tolerance assessment
The product being sold is a GLP-1 program